BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31882457)

  • 1. Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids.
    Holzmann C; Kuepker W; Rommel B; Helmke B; Bullerdiek J
    In Vivo; 2020; 34(1):1-9. PubMed ID: 31882457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation.
    Lu B; Xu J; Pan Z
    J Obstet Gynaecol Res; 2016 Aug; 42(8):990-9. PubMed ID: 27125448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
    Tan A; Salfinger S; Tan J; Cohen P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms.
    Seidman MA; Oduyebo T; Muto MG; Crum CP; Nucci MR; Quade BJ
    PLoS One; 2012; 7(11):e50058. PubMed ID: 23189178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic power morcellation of presumed fibroids.
    Brolmann HA; Sizzi O; Hehenkamp WJ; Rossetti A
    Minerva Ginecol; 2016 Jun; 68(3):352-63. PubMed ID: 26799759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morcellation of occulted sarcomas during laparoscopic myomectomy and hysterectomy for patients with large fibroid uterus.
    Tinelli A; Farghaly SA
    Minerva Ginecol; 2018 Feb; 70(1):84-88. PubMed ID: 28975775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
    Chen Q; Shi H; Lu W; Lu B
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
    Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
    Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery.
    Wong M; De Wilde RL; Isaacson K
    Arch Gynecol Obstet; 2018 Feb; 297(2):285-293. PubMed ID: 29128980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasitic leiomyomas: a systematic review.
    Lete I; González J; Ugarte L; Barbadillo N; Lapuente O; Álvarez-Sala J
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():250-9. PubMed ID: 27359081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
    Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
    JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH; Pritts EA; Olive DL
    Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
    Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
    JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up.
    Ehdaivand S; Simon RA; Sung CJ; Steinhoff MM; Lawrence WD; Quddus MR
    Hum Pathol; 2014 Nov; 45(11):2311-7. PubMed ID: 25257577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
    Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.